Lead sponsor
University of California, San Francisco
8 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
8
Trials led
0
Ongoing
243
Total enrollment
14
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
4
Phase 4
4
Trials by status
Completed
7
Terminated
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal DementiaSymptomatic FTDPh 4Completed81
Treatment of Disturbed Sleep in Progressive Supranuclear Palsy (PSP)Study partner/caregiver requiredPh 4Completed40
A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TPI-287 in Alzheimer's DiseaseAlzheimer's diseasePh 1Completed29
The Effects of the Rivastigmine Patch on Parkinson's Disease With Memory and/or Thinking ProblemsParkinson's disease dementiaPh 4Completed15
A 52 Week Open Label Trial of Memantine for Frontotemporal Lobar DegenerationMMSE ≥15Ph 4Completednot disclosed